Latticework
← Viking Global Investors

Viking Global Investors's 2024Q3 portfolio

Viking Global Investors (Viking Global Investors) held 32 positions as of Sep 30, 2024, with the largest position at 4.1% of the portfolio.

Showing positions still held at the most recent quarter so their historical weights can be reconstructed. Positions that were held in 2024Q3but have since been exited aren't included in this table — for a full point-in-time reconstruction, use the SEC EDGAR filing directly.

Holdings as of Sep 30, 2024 (32)

  1. 1AAPLApple Inc
    % port
    4.1%
    +0.4pp vs prior Qnow 2.6%
  2. 2VVisa Inc-class A Shares
    % port
    3.5%
    now 5.3%
  3. 3FTVFortive Corp
    % port
    3.4%
    +0.5pp vs prior Q
  4. 4PGRProgressive Corp
    % port
    3.2%
    now 0.9%
  5. 5MSFTMicrosoft Corp
    % port
    3.2%
    -0.7pp vs prior Qnow 2.4%
  6. 6APGApi Group Corp
    % port
    3.1%
    -0.8pp vs prior Qnow 0.7%
  7. 7JPMJpmorgan Chase & CO
    % port
    2.8%
    +0.5pp vs prior Qnow 2.2%
  8. 8AMZNAmazon.com Inc
    % port
    2.8%
    -4.1pp vs prior Qnow 0.7%
  9. 9BMRNBiomarin Pharmaceutical Inc
    % port
    2.5%
    +0.3pp vs prior Qnow 1.1%
  10. 10BBIOBridgebio Pharma Inc
    % port
    2.3%
    -0.1pp vs prior Qnow 2.5%
  11. 11(cusip)Roivant Sciences Ltd
    % port
    2.3%
    -0.5pp vs prior Qnow 0.5%
  12. 12SHWSherwin-williams Co/the
    % port
    1.8%
    +1.3pp vs prior Qnow 2.8%
  13. 13CPTCamden Property Trust
    % port
    1.3%
  14. 14MCDMcdonald's Corp
    % port
    1.2%
    -0.6pp vs prior Qnow 3.2%
  15. 15CSXCsx Corp
    % port
    1.2%
    +0.6pp vs prior Qnow 2.1%
  16. 16HCAHca Healthcare Inc
    % port
    1.0%
    +0.2pp vs prior Qnow 1.4%
  17. 17TMUST-mobile US Inc
    % port
    0.9%
    -0.8pp vs prior Qnow 1.7%
  18. 18GOOGLAlphabet Inc-cl A
    % port
    0.8%
    now 1.9%
  19. 19AONAon Plc
    % port
    0.7%
    now 1.0%
  20. 20CCLCarnival Corp
    % port
    0.6%
    now 1.0%
  21. 21ADPTAdaptive Biotechnologies
    % port
    0.6%
    +0.1pp vs prior Qnow 1.2%
  22. 22SCHWSchwab (charles) Corp
    % port
    0.6%
    now 3.9%
  23. 23NAMSNewamsterdam Pharma Company
    % port
    0.5%
    -0.1pp vs prior Qnow 0.4%
  24. 24TSLATesla Inc
    % port
    0.4%
    now 2.6%
  25. 25LABStandard Biotools Inc
    % port
    0.4%
    now 0.2%
  26. 26RRXRegal Rexnord Corp
    % port
    0.4%
    -0.2pp vs prior Qnow 1.6%
  27. 27(cusip)Pharvaris N V
    % port
    0.2%
  28. 28CVNACarvana CO
    % port
    0.2%
    -0.1pp vs prior Qnow 2.4%
  29. 29ORICOric Pharmaceuticals Inc
    % port
    0.1%
  30. 30DNAGinkgo Bioworks Holdings Inc
    % port
    0.1%
  31. 31INBXInhibrx Biosciences Inc
    % port
    0.1%
    now 0.3%
  32. 32TRVITrevi Therapeutics Inc
    % port
    0.1%

13F-HR filings disclose long US-equity positions only. 13Fs don't cover shorts, bonds, derivatives, or non-US listings, so the picture here is the public part of the portfolio — not the whole.

Not investment advice.